bluebird bio, Inc.
BLUE
$4.95
$0.061.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 83.80M | 52.93M | 54.59M | 45.33M | 29.07M |
| Total Other Revenue | 12.00K | 195.00K | 306.00K | 359.00K | 432.00K |
| Total Revenue | 83.81M | 53.12M | 54.90M | 45.69M | 29.50M |
| Cost of Revenue | 89.38M | 78.78M | 76.13M | 53.88M | 33.53M |
| Gross Profit | -5.57M | -25.66M | -21.23M | -8.19M | -4.03M |
| SG&A Expenses | 190.13M | 205.27M | 206.99M | 197.84M | 190.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 0.00 | 0.00 | 0.00 | -92.93M |
| Total Operating Expenses | 351.51M | 371.60M | 405.27M | 379.39M | 273.76M |
| Operating Income | -267.70M | -318.48M | -350.37M | -333.70M | -244.26M |
| Income Before Tax | -240.65M | -292.91M | -319.28M | -300.77M | -212.04M |
| Income Tax Expenses | 70.00K | -83.00K | -25.00K | -126.00K | -126.00K |
| Earnings from Continuing Operations | -240.72 | -292.83 | -319.25 | -300.65 | -211.91 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -240.72M | -292.83M | -319.25M | -300.65M | -211.91M |
| EBIT | -267.70M | -318.48M | -350.37M | -333.70M | -244.26M |
| EBITDA | -206.46M | -262.27M | -302.10M | -295.88M | -215.74M |
| EPS Basic | -24.86 | -35.54 | -45.26 | -48.41 | -37.51 |
| Normalized Basic EPS | -15.35 | -22.04 | -28.29 | -30.27 | -23.46 |
| EPS Diluted | -24.86 | -35.54 | -45.27 | -48.47 | -37.64 |
| Normalized Diluted EPS | -15.35 | -22.04 | -28.29 | -30.27 | -23.46 |
| Average Basic Shares Outstanding | 38.76M | 34.96M | 30.72M | 26.47M | 21.96M |
| Average Diluted Shares Outstanding | 38.76M | 34.96M | 30.72M | 26.47M | 21.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
